V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230002110 | 230006639 | 1.6 | 55.4 | null | 2019-11-19 | 2020-03-24 | Niraparib | 02 | null | NIRAPARIB | 100190382 |
| 230002112 | 230006640 | 1.73 | 65.9 | Palliative (P) | null | 2017-11-27 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101610339 |
| 230002114 | 230006641 | 1.67 | 67.7 | null | 2019-09-27 | 2019-09-28 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 101016107 |
| 230002115 | 230006642 | 1.59 | 73.1 | Palliative (P) | 2019-05-11 | 2019-05-13 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 100114246 |
| 230002118 | 230006645 | 1.62 | 91.9 | null | 2017-01-04 | 2017-01-13 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100138953 |
| 230002121 | 230006646 | 1.55 | 67.7 | null | null | 2020-03-08 | Trial Unspecified | 02 | null | IPILIMUMAB + NIVOLUMAB | 100231171 |
| 230002123 | 230006647 | null | null | null | 2018-08-24 | 2019-05-03 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 100941032 |
| 230002124 | 230006648 | 1.45 | 84 | Palliative (P) | null | 2020-06-29 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100318201 |
| 230002125 | 230006649 | 1.75 | 79.4 | Palliative (P) | 2019-07-07 | 2019-07-14 | null | null | N | LIPOSOMAL DOXORUBICIN | 101100497 |
| 230002127 | 230006651 | 1.57 | 55.5 | Curative (C) | 2020-02-20 | 2020-07-11 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101755948 |
| 230002128 | 230006652 | 1.57 | 95.6 | null | 2019-11-04 | 2019-11-08 | Niraparib | 02 | null | NIRAPARIB | 100303037 |
| 230002129 | 230006653 | 1.52 | 66 | null | 2018-02-15 | 2018-02-27 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101432037 |
| 230002130 | 230006654 | 1.58 | 50.6 | null | 2020-10-11 | 2020-10-11 | Bevacizumab | 02 | null | BEVACIZUMAB | 100943287 |
| 230002131 | 230006655 | 1.62 | 74.5 | Palliative (P) | 2019-11-10 | 2019-12-06 | Olaparib | 02 | N | OLAPARIB | 100061218 |
| 230002134 | 230006658 | 1.56 | 68.6 | Palliative (P) | 2021-08-27 | 2021-10-01 | Bevacizumab 7.5mg/kg | 02 | N | BEVACIZUMAB | 100359729 |
| 230002135 | 230006659 | 1.57 | 66 | null | 2016-11-14 | 2016-11-22 | Rucaparib | 02 | null | RUCAPARIB | 101119295 |
| 230002136 | 230006660 | 1.53 | 79 | null | null | 2020-09-19 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100984193 |
| 230002138 | 230006661 | 1.76 | 58.9 | null | 2020-02-05 | 2020-02-19 | Niraparib | 02 | null | NIRAPARIB | 100730537 |
| 230002139 | 230006662 | 1.52 | 71.55 | Palliative (P) | 2019-03-07 | 2019-03-07 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100761734 |
| 230002141 | 230006663 | 1.67 | 73.5 | Palliative (P) | 2021-11-19 | 2021-11-24 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | PEMBROLIZUMAB | 101257171 |
| 230002144 | 230006665 | 1.53 | 58.1 | Palliative (P) | 2020-11-23 | 2020-11-25 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 100159162 |
| 230002146 | 230006666 | 1.68 | 65 | null | 2021-09-30 | 2021-10-06 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100649868 |
| 230002148 | 230006667 | null | null | null | 2019-10-16 | 2019-10-23 | Olaparib | 02 | null | OLAPARIB | 101606687 |
| 230002151 | 230006669 | 1.48 | 48.4 | Adjuvant (A) | null | 2022-04-10 | null | 01 | N | CARBOPLATIN + LIPOSOMAL DOX | 100520822 |
| 230002152 | 230006670 | null | null | null | 2019-03-19 | 2019-03-25 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 101124121 |
| 230002153 | 230006671 | null | null | null | null | 2019-08-14 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | PEMBROLIZUMAB | 100775832 |
| 230002156 | 230006673 | 1.64 | 84.7 | null | 2017-07-11 | 2017-07-18 | null | null | null | NIVOLUMAB | 101737541 |
| 230002158 | 230006674 | null | null | null | 2021-02-08 | 2021-02-08 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 100331492 |
| 230002160 | 230006676 | null | null | null | 2019-10-14 | 2019-10-15 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100358699 |
| 230002164 | 230006678 | 1.71 | 79.7 | null | null | 2019-08-01 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100317806 |
| 230002169 | 230006679 | null | null | null | 2020-04-17 | 2020-07-16 | null | 02 | null | ICON8B TRIAL | 100012609 |
| 230002170 | 230006680 | 1.58 | 78.3 | Palliative (P) | null | 2019-08-29 | null | 02 | N | CISPLATIN | 100451950 |
| 230002172 | 230006681 | 1.58 | 87.6 | null | null | 2020-03-19 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100755332 |
| 230002173 | 230006682 | null | null | null | 2019-08-04 | 2020-04-17 | Rucaparib | 02 | null | RUCAPARIB | 101098825 |
| 230002175 | 230006683 | null | null | Palliative (P) | 2019-08-19 | 2019-08-25 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | FLUOROURACIL + OXALIPLATIN | 101321904 |
| 230002177 | 230006684 | 1.62 | 78.4 | null | 2021-11-07 | 2021-11-07 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101007442 |
| 230002179 | 230006685 | 1.71 | 55.9 | null | 2017-08-29 | 2017-09-14 | Olaparib | 02 | null | OLAPARIB | 100556662 |
| 230002180 | 230006686 | 1.61 | 99.2 | null | 2021-10-30 | 2021-10-30 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100470366 |
| 230002182 | 230006687 | 0 | 77 | Palliative (P) | 2020-02-12 | 2020-03-03 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101006413 |
| 230002183 | 230006688 | null | null | null | 2016-10-26 | 2016-10-31 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100308560 |
| 230002184 | 230006689 | null | 95 | null | 2020-01-13 | 2020-02-09 | Rucaparib | 02 | null | RUCAPARIB | 100731831 |
| 230002185 | 230006690 | 1.58 | 68.4 | null | 2021-07-23 | 2021-07-25 | Rucaparib | 02 | null | RUCAPARIB | 100048058 |
| 230002186 | 230006691 | 1.67 | 69.1 | null | 2018-12-31 | 2019-01-03 | null | N | null | PACLITAXEL | 100814350 |
| 230002187 | 230006692 | null | null | null | 2018-03-05 | 2019-07-08 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100767357 |
| 230002190 | 230006693 | 1.64 | 79.6 | null | null | 2021-05-19 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101409364 |
| 230002191 | 230006694 | null | null | null | 2019-07-01 | 2019-07-08 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 101547711 |
| 230002193 | 230006696 | 1.76 | null | null | 2021-10-05 | 2022-03-24 | PACLITAXEL | 02 | null | PACLITAXEL | 100645564 |
| 230002194 | 230006697 | 1.46 | 85 | null | null | 2019-11-05 | Niraparib | 02 | null | NIRAPARIB | 101363266 |
| 230002195 | 230006698 | 1.6 | 54 | Neo-adjuvant (N) | 2019-12-28 | 2020-01-06 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100225814 |
| 230002196 | 230006699 | 1.67 | 57.6 | Palliative (P) | 2019-07-28 | 2019-08-11 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100917034 |